Pfizer’s Capital Strategy in 2025: Navigating Debt, M&A, and Market Pressures Amid a Healthcare Dealmaking Boom

from Plocamium Global Insights · host James Tannahill

Pfizer Inc. (NYSE: PFE) stands at a financial crossroads, balancing its capital allocation priorities between business development (BD), debt management, and shareholder returns.

Episode metadata supplied by the publisher feed · Published Feb 5, 2025

Embed this episode

Attribution link and audio player

Ready to play

Pfizer’s Capital Strategy in 2025: Navigating Debt, M&A, and Market Pressures Amid a Healthcare Dealmaking Boom

0:00 4:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Plocamium Global Insights?

This episode is 4 minutes long.

When was this Plocamium Global Insights episode published?

This episode was published on February 5, 2025.

Can I download this Plocamium Global Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!